Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) ROC % : 5.94% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was 5.94%.

As of today (2025-04-06), Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's WACC % is 9.30%. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROC % is 6.29% (calculated using TTM income statement data). Jilin Province Xidian Pharmaceutical Sci-Tech Development Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROC % Historical Data

The historical data trend for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROC % Chart

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Annual Data

Trend

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROC %

Get a 7-Day Free Trial

14.35

11.69

13.02

8.97

7.74

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROC %	Get a 7-Day Free Trial															7.21	1.18	9.93	7.81	5.94

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROC % Calculation

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

	ROC % (A: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2022 )	+	Invested Capital (A: Dec. 2023 ))	/ count )
=	37.625 * ( 1 - 13.39% )	/	( (369.239	+	472.327)	/ 2 )
=	32.5870125	/	420.783
=	7.74 %

where

	Invested Capital		(A: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1017.003	-	31.816	-	( 615.948	-	max(0, 38.736	-	704.172	+	615.948	))
=	369.239

	Invested Capital		(A: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1067.196	-	47.351	-	( 547.518	-	max(0, 53.698	-	633.763	+	547.518	))
=	472.327

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	37.48 * ( 1 - 13.43% )	/	( (522.376	+	570.859)	/ 2 )
=	32.446436	/	546.6175
=	5.94 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	966.153	-	40.345	-	( 403.432	-	max(0, 43.718	-	488.144	+	403.432	))
=	522.376

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	976.929	-	46.709	-	( 359.361	-	max(0, 50.62	-	449.768	+	359.361	))
=	570.859

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co (SZSE:301130) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's WACC % is 9.30%. Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROC % is 6.29% (calculated using TTM income statement data). Jilin Province Xidian Pharmaceutical Sci-Tech Development Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co ROC % Related Terms

Thank you for viewing the detailed overview of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd (SZSE:301130) » Definitions » ROC %

Traded in Other Exchanges

N/A

Address

No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province, Panshi, CHN, 132300

Website

http://www.xidianyy.com

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd is mainly engaged in the research, development, production, and sales of chemical APIs and preparations. It is focused on the development and manufacturing of iron supplement preparations, circulatory disorder treatment drugs, anti-psychotic drugs, and APIs. The company's product portfolio comprises Compound Ferrous Sulfate Folic Acid Tablets, Risperidone Orally Disintegrating Tablets, Escitalopram Oxalate Tablets, Daphne Capsules, Zoledronic Acid for Injection, etc., and various APIs.

Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Headlines

No Headlines